­
PROJECTS

Validation of Facility Utilities

Client: a company that has always been involved in the research, development and marketing of innovative medicines.

Sector: Pharmaceuticals

Objective: to validate a number elements affecting the systems, specifically the points
of use (end point of a distribution network) of utilities serving production, i.e. water, gaseous/liquid nitrogen and compressed air

Project

The client company is a leading international chemical-pharmaceutical producer, engaged for decades in the development of new medicines, the introduction of cutting-edge technologies and innovative health management practices.

The client needed to validate certain elements affecting the plants, specifically the points of use (end point of a distribution network) of the utilities serving production, namely water, gaseous/liquid nitrogen and compressed air.

Our contribution

  • The validation of the utilities was carried out through the drafting and execution of appropriate performance qualification protocols involving chemical and/or microbiological analysis of the most critical points of use.

This criticality was supported by a preliminary risk analysis process in accordance with directive ICH Q9 Quality Risk Management – November 2005.

The choice of points to be monitored (whether new or existing) was then justified and based on the analytical results it was possible to predict a periodic monitoring plan guaranteeing the quality of the points of use in accordance with current regulations and the customer’s internal specifications.

This activity required a considerable commitment and specific expertise from a
technical, documentary, and regulatorypoint of view. For this reason, the client turned to an external service provider.

On the basis of the reference legislation (Official Pharmacopoeia, GxP, Edralex) and internal procedures, the work team analysed the requirements envisaged by the project and prepared a Risk Analysis document in accordance with the FMEA methodology to establish points-of-use criticality.

Once the points of use with a medium/high criticality level (i.e. with a significant risk of contamination of the product or materials) were identified, it was possible to choose which ones to sample and therefore which ones to submit to the chemical/microbiological analyses provided for in the validation protocol.

At the end of the qualification phase for the points of use, a Periodic Monitoring Plan was developed, in which, through a further Risk Analysis process, the points of use to be included in the routine sampling (periodic analyses) were defined.

The project included the installation of both new points of use and modifications to existing points of use; the planned activities originated from several existing projects including: construction of a new laboratory, construction of a new granulation area, and revamping of pre-existing areas.

The complexity of projects related to utility validation activities has required several months of work and continuous collaboration with the various departments of the client company, including the Quality, the Validation, the Production and, the Engineering departments and the chemical and microbiological Laboratories; the need to interface with the company’s different operational areas has highlighted S4BT’s ability to adapt to any context and to establish fruitful cooperation with all work teams

Result

The project contributed to the implementation of a Risk Analysis process which had not been in place until then.

Furthermore, the analysis served as the initial basis of a process aimed at eliminating the numerous microbiological and chemical samplings required from the respective laboratories.

The completed work laid the foundations for a controlled management of sampling plans and analysis in accordance with the current QRM.

CONSULTANCY SERVICES PURCHASED BY THE CLIENT COMPANY
REQUEST more information

Project

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit

0
Digitised processes
0 k
Projects completed in 2019
CLIENT

Pharmaceutical Company

An international pharmaceutical organisation specialising in the clinical and commercial development and production of pharmaceutical products with a high degree of toxicity.

Home office

Digital Company

Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar 

Home office

Petshop Company

Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar 

PROBLEM

Conditioner Company

Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar 

retail office

Card Rental

Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar 

Home office

Expedition Company

Lorem ipsum dolor sit amet, consectetur sit a sit fadipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar